PLOS MED 润色咨询

PLOS MEDICINE

出版年份:2004 年文章数:2925 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2175503, encodeId=0c0a21e5503c9, content=兽医临床方面的文章收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35bc2554734, createdName=1254ccbfm98(暂无昵称), createdTime=Sun Dec 17 21:12:51 CST 2023, time=2023-12-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2109961, encodeId=aa40210996127, content=收生信相关的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435d8428186, createdName=ms1000000387850430, createdTime=Thu Jan 12 14:30:24 CST 2023, time=2023-01-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1200921, encodeId=8a18120092152, content=PLOS Medicine is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cdf5553816, createdName=liuchenxiao, createdTime=Wed Mar 09 16:10:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096251, encodeId=5027109625112, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096252, encodeId=2d5c1096252d6, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893949, encodeId=542b8939496c, content=有没有人中过啊求分享经验!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Fri Oct 23 14:26:53 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571831, encodeId=f7bc5e1831ca, content=随便找个国内的中文期刊,百度翻译,调整格式,然后投过去。几个月之后,审稿人全部**了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c1f2062862, createdName=labghost, createdTime=Mon Jun 03 19:40:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523228, encodeId=67ef52322857, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:国内发表很少,也是顶级的医学综合类期刊了。与内科学年鉴一个级别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=741, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jun 07 13:47:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474574, encodeId=a96f4e457488, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:可以接受一些战略性,产业性,发展性文章,与纯粹学术性或临床类杂志有所不同。内容比较自由,但要求有高度。国内读者投稿,基本都被拒的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=994, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medicine, createdTime=Fri Mar 25 17:06:00 CST 2011, time=2011-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469402, encodeId=ca894694025f, content=不过如果投不中的话,它会建议你投PLOS ONE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=GASTROENTEROLOGY, createdTime=Fri Nov 06 10:39:00 CST 2009, time=2009-11-06, status=1, ipAttribution=)]
    2023-12-17 1254ccbfm98(暂无昵称) 来自河南省

    兽医临床方面的文章收吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2175503, encodeId=0c0a21e5503c9, content=兽医临床方面的文章收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35bc2554734, createdName=1254ccbfm98(暂无昵称), createdTime=Sun Dec 17 21:12:51 CST 2023, time=2023-12-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2109961, encodeId=aa40210996127, content=收生信相关的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435d8428186, createdName=ms1000000387850430, createdTime=Thu Jan 12 14:30:24 CST 2023, time=2023-01-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1200921, encodeId=8a18120092152, content=PLOS Medicine is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cdf5553816, createdName=liuchenxiao, createdTime=Wed Mar 09 16:10:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096251, encodeId=5027109625112, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096252, encodeId=2d5c1096252d6, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893949, encodeId=542b8939496c, content=有没有人中过啊求分享经验!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Fri Oct 23 14:26:53 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571831, encodeId=f7bc5e1831ca, content=随便找个国内的中文期刊,百度翻译,调整格式,然后投过去。几个月之后,审稿人全部**了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c1f2062862, createdName=labghost, createdTime=Mon Jun 03 19:40:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523228, encodeId=67ef52322857, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:国内发表很少,也是顶级的医学综合类期刊了。与内科学年鉴一个级别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=741, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jun 07 13:47:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474574, encodeId=a96f4e457488, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:可以接受一些战略性,产业性,发展性文章,与纯粹学术性或临床类杂志有所不同。内容比较自由,但要求有高度。国内读者投稿,基本都被拒的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=994, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medicine, createdTime=Fri Mar 25 17:06:00 CST 2011, time=2011-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469402, encodeId=ca894694025f, content=不过如果投不中的话,它会建议你投PLOS ONE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=GASTROENTEROLOGY, createdTime=Fri Nov 06 10:39:00 CST 2009, time=2009-11-06, status=1, ipAttribution=)]
    2023-01-12 ms1000000387850430 来自江苏省

    收生信相关的吗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2175503, encodeId=0c0a21e5503c9, content=兽医临床方面的文章收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35bc2554734, createdName=1254ccbfm98(暂无昵称), createdTime=Sun Dec 17 21:12:51 CST 2023, time=2023-12-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2109961, encodeId=aa40210996127, content=收生信相关的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435d8428186, createdName=ms1000000387850430, createdTime=Thu Jan 12 14:30:24 CST 2023, time=2023-01-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1200921, encodeId=8a18120092152, content=PLOS Medicine is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cdf5553816, createdName=liuchenxiao, createdTime=Wed Mar 09 16:10:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096251, encodeId=5027109625112, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096252, encodeId=2d5c1096252d6, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893949, encodeId=542b8939496c, content=有没有人中过啊求分享经验!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Fri Oct 23 14:26:53 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571831, encodeId=f7bc5e1831ca, content=随便找个国内的中文期刊,百度翻译,调整格式,然后投过去。几个月之后,审稿人全部**了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c1f2062862, createdName=labghost, createdTime=Mon Jun 03 19:40:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523228, encodeId=67ef52322857, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:国内发表很少,也是顶级的医学综合类期刊了。与内科学年鉴一个级别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=741, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jun 07 13:47:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474574, encodeId=a96f4e457488, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:可以接受一些战略性,产业性,发展性文章,与纯粹学术性或临床类杂志有所不同。内容比较自由,但要求有高度。国内读者投稿,基本都被拒的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=994, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medicine, createdTime=Fri Mar 25 17:06:00 CST 2011, time=2011-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469402, encodeId=ca894694025f, content=不过如果投不中的话,它会建议你投PLOS ONE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=GASTROENTEROLOGY, createdTime=Fri Nov 06 10:39:00 CST 2009, time=2009-11-06, status=1, ipAttribution=)]
    2022-03-09 liuchenxiao

    PLOS Medicine is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2175503, encodeId=0c0a21e5503c9, content=兽医临床方面的文章收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35bc2554734, createdName=1254ccbfm98(暂无昵称), createdTime=Sun Dec 17 21:12:51 CST 2023, time=2023-12-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2109961, encodeId=aa40210996127, content=收生信相关的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435d8428186, createdName=ms1000000387850430, createdTime=Thu Jan 12 14:30:24 CST 2023, time=2023-01-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1200921, encodeId=8a18120092152, content=PLOS Medicine is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cdf5553816, createdName=liuchenxiao, createdTime=Wed Mar 09 16:10:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096251, encodeId=5027109625112, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096252, encodeId=2d5c1096252d6, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893949, encodeId=542b8939496c, content=有没有人中过啊求分享经验!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Fri Oct 23 14:26:53 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571831, encodeId=f7bc5e1831ca, content=随便找个国内的中文期刊,百度翻译,调整格式,然后投过去。几个月之后,审稿人全部**了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c1f2062862, createdName=labghost, createdTime=Mon Jun 03 19:40:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523228, encodeId=67ef52322857, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:国内发表很少,也是顶级的医学综合类期刊了。与内科学年鉴一个级别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=741, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jun 07 13:47:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474574, encodeId=a96f4e457488, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:可以接受一些战略性,产业性,发展性文章,与纯粹学术性或临床类杂志有所不同。内容比较自由,但要求有高度。国内读者投稿,基本都被拒的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=994, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medicine, createdTime=Fri Mar 25 17:06:00 CST 2011, time=2011-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469402, encodeId=ca894694025f, content=不过如果投不中的话,它会建议你投PLOS ONE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=GASTROENTEROLOGY, createdTime=Fri Nov 06 10:39:00 CST 2009, time=2009-11-06, status=1, ipAttribution=)]
    2021-12-29 学医的彭于晏

    想要做但未做的实验是否可以放到讨论中?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2175503, encodeId=0c0a21e5503c9, content=兽医临床方面的文章收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35bc2554734, createdName=1254ccbfm98(暂无昵称), createdTime=Sun Dec 17 21:12:51 CST 2023, time=2023-12-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2109961, encodeId=aa40210996127, content=收生信相关的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435d8428186, createdName=ms1000000387850430, createdTime=Thu Jan 12 14:30:24 CST 2023, time=2023-01-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1200921, encodeId=8a18120092152, content=PLOS Medicine is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cdf5553816, createdName=liuchenxiao, createdTime=Wed Mar 09 16:10:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096251, encodeId=5027109625112, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096252, encodeId=2d5c1096252d6, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893949, encodeId=542b8939496c, content=有没有人中过啊求分享经验!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Fri Oct 23 14:26:53 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571831, encodeId=f7bc5e1831ca, content=随便找个国内的中文期刊,百度翻译,调整格式,然后投过去。几个月之后,审稿人全部**了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c1f2062862, createdName=labghost, createdTime=Mon Jun 03 19:40:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523228, encodeId=67ef52322857, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:国内发表很少,也是顶级的医学综合类期刊了。与内科学年鉴一个级别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=741, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jun 07 13:47:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474574, encodeId=a96f4e457488, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:可以接受一些战略性,产业性,发展性文章,与纯粹学术性或临床类杂志有所不同。内容比较自由,但要求有高度。国内读者投稿,基本都被拒的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=994, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medicine, createdTime=Fri Mar 25 17:06:00 CST 2011, time=2011-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469402, encodeId=ca894694025f, content=不过如果投不中的话,它会建议你投PLOS ONE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=GASTROENTEROLOGY, createdTime=Fri Nov 06 10:39:00 CST 2009, time=2009-11-06, status=1, ipAttribution=)]
    2021-12-28 Mia

    讨论的字数一般控制在多少?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2175503, encodeId=0c0a21e5503c9, content=兽医临床方面的文章收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35bc2554734, createdName=1254ccbfm98(暂无昵称), createdTime=Sun Dec 17 21:12:51 CST 2023, time=2023-12-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2109961, encodeId=aa40210996127, content=收生信相关的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435d8428186, createdName=ms1000000387850430, createdTime=Thu Jan 12 14:30:24 CST 2023, time=2023-01-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1200921, encodeId=8a18120092152, content=PLOS Medicine is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cdf5553816, createdName=liuchenxiao, createdTime=Wed Mar 09 16:10:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096251, encodeId=5027109625112, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096252, encodeId=2d5c1096252d6, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893949, encodeId=542b8939496c, content=有没有人中过啊求分享经验!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Fri Oct 23 14:26:53 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571831, encodeId=f7bc5e1831ca, content=随便找个国内的中文期刊,百度翻译,调整格式,然后投过去。几个月之后,审稿人全部**了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c1f2062862, createdName=labghost, createdTime=Mon Jun 03 19:40:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523228, encodeId=67ef52322857, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:国内发表很少,也是顶级的医学综合类期刊了。与内科学年鉴一个级别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=741, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jun 07 13:47:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474574, encodeId=a96f4e457488, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:可以接受一些战略性,产业性,发展性文章,与纯粹学术性或临床类杂志有所不同。内容比较自由,但要求有高度。国内读者投稿,基本都被拒的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=994, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medicine, createdTime=Fri Mar 25 17:06:00 CST 2011, time=2011-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469402, encodeId=ca894694025f, content=不过如果投不中的话,它会建议你投PLOS ONE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=GASTROENTEROLOGY, createdTime=Fri Nov 06 10:39:00 CST 2009, time=2009-11-06, status=1, ipAttribution=)]
    2020-10-23 医心唯你

    有没有人中过啊求分享经验!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2175503, encodeId=0c0a21e5503c9, content=兽医临床方面的文章收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35bc2554734, createdName=1254ccbfm98(暂无昵称), createdTime=Sun Dec 17 21:12:51 CST 2023, time=2023-12-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2109961, encodeId=aa40210996127, content=收生信相关的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435d8428186, createdName=ms1000000387850430, createdTime=Thu Jan 12 14:30:24 CST 2023, time=2023-01-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1200921, encodeId=8a18120092152, content=PLOS Medicine is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cdf5553816, createdName=liuchenxiao, createdTime=Wed Mar 09 16:10:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096251, encodeId=5027109625112, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096252, encodeId=2d5c1096252d6, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893949, encodeId=542b8939496c, content=有没有人中过啊求分享经验!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Fri Oct 23 14:26:53 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571831, encodeId=f7bc5e1831ca, content=随便找个国内的中文期刊,百度翻译,调整格式,然后投过去。几个月之后,审稿人全部**了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c1f2062862, createdName=labghost, createdTime=Mon Jun 03 19:40:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523228, encodeId=67ef52322857, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:国内发表很少,也是顶级的医学综合类期刊了。与内科学年鉴一个级别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=741, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jun 07 13:47:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474574, encodeId=a96f4e457488, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:可以接受一些战略性,产业性,发展性文章,与纯粹学术性或临床类杂志有所不同。内容比较自由,但要求有高度。国内读者投稿,基本都被拒的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=994, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medicine, createdTime=Fri Mar 25 17:06:00 CST 2011, time=2011-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469402, encodeId=ca894694025f, content=不过如果投不中的话,它会建议你投PLOS ONE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=GASTROENTEROLOGY, createdTime=Fri Nov 06 10:39:00 CST 2009, time=2009-11-06, status=1, ipAttribution=)]
    2019-06-03 labghost

    随便找个国内的中文期刊,百度翻译,调整格式,然后投过去。几个月之后,审稿人全部**了。

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2175503, encodeId=0c0a21e5503c9, content=兽医临床方面的文章收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35bc2554734, createdName=1254ccbfm98(暂无昵称), createdTime=Sun Dec 17 21:12:51 CST 2023, time=2023-12-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2109961, encodeId=aa40210996127, content=收生信相关的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435d8428186, createdName=ms1000000387850430, createdTime=Thu Jan 12 14:30:24 CST 2023, time=2023-01-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1200921, encodeId=8a18120092152, content=PLOS Medicine is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cdf5553816, createdName=liuchenxiao, createdTime=Wed Mar 09 16:10:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096251, encodeId=5027109625112, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096252, encodeId=2d5c1096252d6, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893949, encodeId=542b8939496c, content=有没有人中过啊求分享经验!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Fri Oct 23 14:26:53 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571831, encodeId=f7bc5e1831ca, content=随便找个国内的中文期刊,百度翻译,调整格式,然后投过去。几个月之后,审稿人全部**了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c1f2062862, createdName=labghost, createdTime=Mon Jun 03 19:40:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523228, encodeId=67ef52322857, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:国内发表很少,也是顶级的医学综合类期刊了。与内科学年鉴一个级别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=741, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jun 07 13:47:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474574, encodeId=a96f4e457488, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:可以接受一些战略性,产业性,发展性文章,与纯粹学术性或临床类杂志有所不同。内容比较自由,但要求有高度。国内读者投稿,基本都被拒的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=994, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medicine, createdTime=Fri Mar 25 17:06:00 CST 2011, time=2011-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469402, encodeId=ca894694025f, content=不过如果投不中的话,它会建议你投PLOS ONE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=GASTROENTEROLOGY, createdTime=Fri Nov 06 10:39:00 CST 2009, time=2009-11-06, status=1, ipAttribution=)]
    2016-06-07 lovetcm

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:国内发表很少,也是顶级的医学综合类期刊了。与内科学年鉴一个级别

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2175503, encodeId=0c0a21e5503c9, content=兽医临床方面的文章收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35bc2554734, createdName=1254ccbfm98(暂无昵称), createdTime=Sun Dec 17 21:12:51 CST 2023, time=2023-12-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2109961, encodeId=aa40210996127, content=收生信相关的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435d8428186, createdName=ms1000000387850430, createdTime=Thu Jan 12 14:30:24 CST 2023, time=2023-01-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1200921, encodeId=8a18120092152, content=PLOS Medicine is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cdf5553816, createdName=liuchenxiao, createdTime=Wed Mar 09 16:10:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096251, encodeId=5027109625112, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096252, encodeId=2d5c1096252d6, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893949, encodeId=542b8939496c, content=有没有人中过啊求分享经验!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Fri Oct 23 14:26:53 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571831, encodeId=f7bc5e1831ca, content=随便找个国内的中文期刊,百度翻译,调整格式,然后投过去。几个月之后,审稿人全部**了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c1f2062862, createdName=labghost, createdTime=Mon Jun 03 19:40:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523228, encodeId=67ef52322857, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:国内发表很少,也是顶级的医学综合类期刊了。与内科学年鉴一个级别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=741, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jun 07 13:47:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474574, encodeId=a96f4e457488, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:可以接受一些战略性,产业性,发展性文章,与纯粹学术性或临床类杂志有所不同。内容比较自由,但要求有高度。国内读者投稿,基本都被拒的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=994, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medicine, createdTime=Fri Mar 25 17:06:00 CST 2011, time=2011-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469402, encodeId=ca894694025f, content=不过如果投不中的话,它会建议你投PLOS ONE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=GASTROENTEROLOGY, createdTime=Fri Nov 06 10:39:00 CST 2009, time=2009-11-06, status=1, ipAttribution=)]
    2011-03-25 medicine

    审稿速度:3.0 | 投稿命中率:20.0
    经验分享:可以接受一些战略性,产业性,发展性文章,与纯粹学术性或临床类杂志有所不同。内容比较自由,但要求有高度。国内读者投稿,基本都被拒的。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2175503, encodeId=0c0a21e5503c9, content=兽医临床方面的文章收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35bc2554734, createdName=1254ccbfm98(暂无昵称), createdTime=Sun Dec 17 21:12:51 CST 2023, time=2023-12-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2109961, encodeId=aa40210996127, content=收生信相关的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435d8428186, createdName=ms1000000387850430, createdTime=Thu Jan 12 14:30:24 CST 2023, time=2023-01-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1200921, encodeId=8a18120092152, content=PLOS Medicine is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cdf5553816, createdName=liuchenxiao, createdTime=Wed Mar 09 16:10:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096251, encodeId=5027109625112, content=想要做但未做的实验是否可以放到讨论中?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096252, encodeId=2d5c1096252d6, content=讨论的字数一般控制在多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893949, encodeId=542b8939496c, content=有没有人中过啊求分享经验!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Fri Oct 23 14:26:53 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571831, encodeId=f7bc5e1831ca, content=随便找个国内的中文期刊,百度翻译,调整格式,然后投过去。几个月之后,审稿人全部**了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c1f2062862, createdName=labghost, createdTime=Mon Jun 03 19:40:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523228, encodeId=67ef52322857, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:国内发表很少,也是顶级的医学综合类期刊了。与内科学年鉴一个级别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=741, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jun 07 13:47:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474574, encodeId=a96f4e457488, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:可以接受一些战略性,产业性,发展性文章,与纯粹学术性或临床类杂志有所不同。内容比较自由,但要求有高度。国内读者投稿,基本都被拒的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=994, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medicine, createdTime=Fri Mar 25 17:06:00 CST 2011, time=2011-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469402, encodeId=ca894694025f, content=不过如果投不中的话,它会建议你投PLOS ONE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=GASTROENTEROLOGY, createdTime=Fri Nov 06 10:39:00 CST 2009, time=2009-11-06, status=1, ipAttribution=)]
    2009-11-06 GASTROENTEROLOGY

    不过如果投不中的话,它会建议你投PLOS ONE

    0

共17条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分